Skip to main content
. 2022 Feb 12;22:72. doi: 10.1186/s12886-022-02282-5

Fig. 4.

Fig. 4

Subgroup analysis based on country. The prevalence rates were 57% (95% CI 39 to 74) in China, 61% (95% CI 58 to 63) in Germany, 83% (95% CI 78 to 88) in Japan, 85% (95% CI 64 to 97) in Korea and 64% (95% CI 55 to 73) in the USA